Use of antiretroviral HIV post-exposure prophylaxis in sexually abused children and adolescents treated in an inner-city pediatric emergency department

Child Abuse and Neglect

Volumn 30, Issue 8, 2006, Pages 919-927

  Fajman, Nancy ^a   Wright, Richelle ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA DEPARTMENT OF HUMAN RESOURCES   (United States)

Author keywords

Human immunodeficiency virus; Prophylaxis; Sexual abuse

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLEEDING; CHILD; CHILD SEXUAL ABUSE; EMERGENCY WARD; FEMALE; GYNECOLOGIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; MALE; NEGRO; PEDIATRIC WARD; PROPHYLAXIS; RETROSPECTIVE STUDY; SEXUAL ABUSE;

ADOLESCENT; ANTI-HIV AGENTS; CHILD; CHILD ABUSE, SEXUAL; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; GEORGIA; HIV INFECTIONS; HUMANS; INFANT; MALE; MEDICAL RECORDS; PREVALENCE; RETROSPECTIVE STUDIES; URBAN POPULATION;

EID: 33750607432     PISSN: 01452134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chiabu.2006.02.013     Document Type: Article

References (31)

1. AIDS Action. (n.d.). State facts. HIV/AIDS in Georgia. Retrieved January, 2004 from www.aidsaction.org/communications/publications/statefactsheets/pdfs/georgia_2003.pdf.
2. Babl F.E., Cooper E.R., Damon B., Louie T., Kharasch S., and Harris J.A. HIV postexposure prophylaxis for children and adolescents. American Journal of Emergency Medicine 18 (2000) 282-287
3. Babl F.E., Cooper E.R., Kastner B., and Kharasch S. Prophylaxis against possible human immunodeficiency virus exposure after nonoccupational needlestick injuries or sexual assaults in children and adolescents. Archives of Pediatric & Adolescent Medicine 155 (2001) 680-682
4. Bamberger J.D., Waldo C.R., Gerberding J.L., and Katz M.H. Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault. The American Journal of Medicine 106 (1999) 323-326
5. Cardo D.M., Culver D.H., Ciesielski C.A., Srivastava P.U., Marcus R., Abiteboul D., Heptonstall J., Ippolito G., Lot F., McKibben P.S., and Bell D.M. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. New England Journal of Medicine 337 (1997) 1485-1489
6. Centers for Disease Control and Prevention. (1998a). Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. Public Health Service Statement. MMWR 47, RR-17.
7. Centers for Disease Control and Prevention. (1998b). Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR 47, RR-5.
8. Centers for Disease Control and Prevention. (2001). Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR 50, RR-11.
9. Centers for Disease Control and Prevention. (2002). Sexually transmitted diseases treatment guidelines 2002. MMWR 51, RR-6.
10. Centers for Disease Control and Prevention. (2005). Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. MMWR 54, RR-02.
11. Centers for Disease Control and Prevention. (n.d.). HIV/AIDS Surveillance Report 2002. Retrieved January, 2004 from www.cdc.gov/hiv/stats/hasrlink.htm.
12. D'Amico R., Pinto L.A., Meyer P., Landay A.L., Harris A.A., Clerici M., Berzofsky J.A., Shearer G.M., and Kessler H.A. Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers. Infection Control and Hospital Epidemiology 20 (1999) 428-430
13. Dean, A. G., Arner, T. G., Sunki, G. G., Friedman, R., Lantinga, M., Sangam, S., Zubieta, J. C., Sullivan, K. M., Brendel, K. A., Gao, Z., Fontaine, N., Shu, M., & Fuller, G. (2005). Epi Info, a database and statistics program for public health professionals. [Computer software]. Centers for Disease Control and Prevention, Atlanta, GA.
14. Gellert G.A., Durfee M.J., Berkowitz C.D., Higgins K.V., and Tubiolo V.C. Situational and sociodemographic characteristics of children infected with human immunodeficiency virus from pediatric sexual abuse. Pediatrics 91 (1993) 39-44
15. Georgia Department of Human Resources. (2002). Year 2002 epidemiologic profile for HIV prevention community planning in Georgia.
16. Havens P.L., and The American Academy of Pediatrics Committee on Pediatric AIDS. Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus. Pediatrics 111 (2003) 1475-1489
17. Leiderman I.Z. A child with HIV infection. [Letter to the editor]. Journal of the American Medical Association 256 (1986) 3094
18. Limb S., Kawsar M., and Forster G.E. HIV prophylaxis after sexual assault: The experience of a sexual assault service in London. International Journal of STD & AIDS 13 (2002) 602-605
19. Lindegren M.L., Hanson I.C., Hammett T.A., Beil J., Fleming L., Ward J.W., and and for the Sexual Transmission of HIV Infection in Children Working Group. Sexual abuse of children: Intersection with the HIV epidemic. Pediatrics 102 (1998) e46
20. Lurie P., Miller S., Hecht F., Chesney M., and Lo B. Postexposure prophylaxis after nonoccupational HIV exposure. Journal of the American Medical Association 280 (1998) 1769-1773
21. Merchant R.C., and Keshavarz R. Human immunodeficiency virus postexposure prophylaxis for adolescents and children. Pediatrics 108 (2001) e38
22. New York State Department of Health AIDS Institute. (2001). HIV prophylaxis following sexual assault: Guidelines for adults and adolescents. Retrieved from http://www.hivguidelines.org/.
23. New York State Department of Health AIDS Institute (2002). HIV post-exposure prophylaxis for children beyond the perinatal period. Retrieved from http://www.hivguidelines.org/.
24. Otten R.A., Smith D.K., Adams D.R., Pullium J.K., Jackson E., Kim C.N., Jaffe H., Janssen R., Butera S., and Folks T.M. Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2). Journal of Virology 74 (2000) 9771-9775
25. Pickering L.K. In: Pickering L.K. (Ed). Red book: Report of the committee on infectious diseases. 26th ed. (2003), American Academy of Pediatrics, Elk Grove Village, IL
26. Schechter, M., Lago, R. F., Ismerio, R., Mendelsohn, M. B., & Harrison L. H. (2002, February). Acceptability, behavioral impact, and possible efficacy of post-sexual-exposure chemoprophylaxis (PEP) for HIV. Abstract presented at the 9th Conference on Retroviruses and Opportunistic Infections, Seattle Washington.
27. Siegel R., Christie C., Myers M., Duma E., and Green L. Incest and pneumocystis carinii pneumonia in a 12-year-old girl: A case for early human immunodeficiency virus testing in sexually abused children. Pediatric Infectious Disease Journal 11 (1992) 681-682
28. US Department of Health and Human Services. (2002). Public Health Service task force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Atlanta, GA.
29. Weinberg G.A. Postexposure prophylaxis against human immunodeficiency virus infection after sexual assault. Pediatric Infectious Disease Journal 21 (2002) 959-960
30. Wiebe E.R., Comay S.E., McGregor M., and Ducceschi S. Offering HIV prophylaxis to people who have been sexually assaulted: 16 months' experience in a sexual assault service. Canadian Medical Association Journal 162 (2000) 641-645
31. Wulfsohn A., Venter W. D. F., Schultze D., Levey M., & Sanne I. M. (2001, February). Post-exposure prophylaxis after sexual assault in South Africa. Abstract presented at the 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA.